Marcel Bonn-Miller
9Patents
5h-index
4Co-inventors
48Inventor score
Filing activity: Sep 27, 2018 → Aug 30, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10471022B2 | Treatment of fragile X syndrome with cannabidiol | Human Necessities | 12 | Active |
| US10213390B1 | Treatment of fragile X syndrome with cannabidiol | Human Necessities | 12 | Active |
| US10314792B2 | Treatment of autism with cannabidiol | Human Necessities | 12 | Active |
| US10568848B2 | Treatment of autism with cannabidiol | Human Necessities | 12 | Active |
| US10758497B2 | Treatment of fragile x syndrome with cannabidiol | Human Necessities | 12 | Active |
| US11458110B2 | Treatment of Fragile X Syndrome with cannabidiol | Human Necessities | 2 | Active |
| US11779549B2 | Treatment of Fragile X Syndrome with cannabidiol | Human Necessities | 1 | Active |
| US12226373B2 | Treatment of fragile X syndrome with cannabidiol | Human Necessities | 0 | Active |
| US12213951B2 | Treatment of autism with cannabidiol | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.